Publicaciones en colaboración con investigadores/as de Goethe University Frankfurt (22)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Best original research presented at the 24th European Congress on Gynaecological Oncology—Best of ESGO 2023

    International Journal of Gynecological Cancer, Vol. 34, Núm. 4, pp. 610-618

  2. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  3. Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

    Leukemia Research, Vol. 134

2022

  1. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Surgical management of the axilla in clinically node‐positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: Current status, knowledge gaps, and rationale for the eubreast‐03 axsana study

    Cancers, Vol. 13, Núm. 7

2020

  1. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

    Radiotherapy and Oncology

2017

  1. Global position paper on cardiovascular regenerative medicine

    European Heart Journal

  2. Interdisciplinary European Guidelines on metabolic and bariatric surgery

    Gastroenterologie a Hepatologie, Vol. 71, Núm. 6, pp. 487-500

  3. Iron affects Ire1 clustering propensity and the amplitude of endoplasmic reticulum stress signaling

    Journal of Cell Science, Vol. 130, Núm. 19, pp. 3222-3233

2016

  1. Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): A randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICOENGOT- GCIG intergroup study (HECTOR)

    Annals of Oncology, Vol. 27, Núm. 12, pp. 2236-2241

2015

  1. A core of kinase-regulated interactomes defines the neoplastic MDSC lineage

    Oncotarget, Vol. 6, Núm. 29, pp. 27160-27175

2014

  1. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

    PLoS ONE, Vol. 9, Núm. 6

  2. Interdisciplinary European guidelines on metabolic and bariatric surgery

    Obesity Surgery, Vol. 24, Núm. 1, pp. 42-55

  3. Interdisciplinární Evropská doporučení metabolické a bariatrické chirurgie

    Diabetologie Metabolismus Endokrinologie Vyziva

2013

  1. Interdisciplinary European guidelines on metabolic and bariatric surgery

    Obesity Facts, Vol. 6, Núm. 5, pp. 449-468

  2. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Nature Genetics, Vol. 45, Núm. 12, pp. 1452-1458

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine

2006

  1. Use of recombinant activated factor VII (Novoseven) in trauma and surgery: Analysis of outcomes reported to an international registry

    Journal of Intensive Care Medicine, Vol. 21, Núm. 1, pp. 27-39